WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved PCORI investing up to $600 million in patient-centered comparative clinical effectiveness research (CER) through the development…

WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) today announced funding awards totaling $123 million to support 15 new research studies. These studies aim to fill evidence gaps, enhance…

WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) today announced funding awards totaling $96 million to support 18 new research studies. These studies aim to fill evidence gaps and…

WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) has approved funding awards totaling $258 million to support 26 new research studies. These studies aim to fill evidence gaps and…

WASHINGTON, DC—The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved several slates of funding awards totaling about $71.5 million to support 12 new comparative clinical effectiveness research (CER)…

WASHINGTON, DC—The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved two slates of research funding awards totaling $49.5 million to support nine new comparative clinical effectiveness research (CER)…

WASHINGTON, DC—The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved an award slate with $32.7 million for a large, multi-phase comparative clinical effectiveness research (CER) study to compare…

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved $254 million in funding for 28 new research studies aimed at eliminating disparities in maternal morbidity and mortality, preventing suicide among young people, and improving behavioral health, maternal and infant outcomes, cancer care, surgical care and outcomes for people with chronic illnesses such as cardiovascular disease and diabetes.

WASHINGTON, DC—Two new studies comparing ways to boost COVID-19 vaccination rates that were approved for nearly $11 million in new funding today by the Patient-Centered Outcomes Research Institute (PCORI) aim…

WASHINGTON, DC — Patients, clinicians and families facing uncertainty about their choices for managing Type 2 diabetes and rare diseases will gain new evidence to inform their decision making from…

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved $34 million to fund seven comparative clinical effectiveness research (CER) studies designed to improve care for health conditions that impose high burdens on patients, their families and the health care system. They also acknowledged its newest seven board members, appointed by the US Government Accountability Office in late September, at their first public meeting.

WASHINGTON, DC — In response to the coronavirus pandemic, the Patient-Centered Outcomes Research Institute (PCORI) has approved $22.6 million in funding for seven studies assessing various health care approaches to…

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today, building on its rapid response to the COVID-19 health crisis, approved allocating up to $50 million in additional funding for new projects in PCORI’s COVID-19 funding opportunities, as well as enhancements to existing PCORI-funded studies. The research will help provide answers to difficult COVID-19 related questions faced by patients, providers and health systems.

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors at its March 2 meeting approved up to $195 million for upcoming funding opportunities and $16 million for research projects comparing the most effective ways to treat a range of health conditions that impose high burdens on patients, their families and the health care system.

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved $12.2 million to fund four studies comparing the most effective ways to treat a range of health conditions that impose high burdens on patients, their families and the healthcare system.

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved $70 million to fund 21 studies and related projects designed to improve care for health conditions that impose high burdens on patients, their families and the healthcare system.

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved $29.3 million to fund 11 studies comparing the best ways to prevent or treat a range of health conditions that impose high burdens on patients, caregivers and the healthcare system.

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved $2.3 million to fund two projects designed to advance the spread and use of PCORI-funded research findings in real-world practice. Both awards were made through PCORI’s Dissemination and Implementation initiative.

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved $44.6 million to fund 12 studies comparing the best ways to treat a range of health conditions that impose high burdens on patients, caregivers and the healthcare system.

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved $3.8 million to fund two projects designed to use shared decision making to disseminate and implement PCORI research findings and to simultaneously study ways of building shared decision making into clinical care. The Board also approved nominations for a new Chair and Co-Chair for PCORI’s Advisory Panel on Clinical Effectiveness and Decision Science.

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved $2.8 million to fund two projects designed to speed the use of results of PCORI-funded studies into practice. The Board also approved a PCORnet funding announcement and adopted new methodology standards.

Kawasaki disease is a rare form of cardiovascular disease that mainly affects children. The condition causes widespread inflammation and can lead to focal swelling, or aneurysm formation, of the arteries…